Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized multicenter study of calcium and magnesium infusions to prevent oxaliplatin-induced neurotoxicity in adjuvant colon cancer treatment
2005-005357-21Phase 3Active
- Sponsor
- ACROSS Group
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium sulfate, calcium gluconate in colon adenocarcinoma, sponsored by ACROSS Group. Started Mar 2006; status: active.
02
Drugs
magnesium sulfatecalcium gluconate
03
Conditions
colon adenocarcinoma
Beyond the preview
Go deeper on 2005-005357-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005357-21.